Insider Transactions in Q3 2020 at Bei Gene, Ltd. (BGNE)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2020
|
Jane Huang CMO, Hematology |
SELL
Open market or private sale
|
Direct |
1,500
-62.9%
|
$420,000
$280.16 P/Share
|
|
Sep 29
2020
|
Jane Huang CMO, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$43,500
$29.49 P/Share
|
|
Sep 29
2020
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,303
-34.04%
|
$6,478,234
$278.75 P/Share
|
|
Sep 28
2020
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
31,000
-57.33%
|
$8,680,000
$280.38 P/Share
|
|
Aug 25
2020
|
Amgen Inc > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
59,390
+0.32%
|
$14,728,720
$248.49 P/Share
|
|
Aug 24
2020
|
Amgen Inc > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
59,390
+0.32%
|
$14,194,210
$239.1 P/Share
|
|
Aug 21
2020
|
Amgen Inc > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
64,176
+0.35%
|
$14,760,480
$230.18 P/Share
|
|
Aug 20
2020
|
Amgen Inc > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
64,176
+0.35%
|
$15,017,184
$234.99 P/Share
|
|
Aug 19
2020
|
Amgen Inc > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
64,176
+0.35%
|
$15,017,184
$234.88 P/Share
|
|
Aug 18
2020
|
Amgen Inc > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+0.22%
|
$9,200,000
$230.18 P/Share
|
|
Jul 15
2020
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
14,584,180
+45.61%
|
$204,178,520
$14.23 P/Share
|
|
Jul 15
2020
|
Amgen Inc > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
29,614,832
+11.14%
|
$414,607,648
$14.23 P/Share
|